Softwr

Research · head to head

Greenphire vs Reduct

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
Reduct logo

Reduct

Research

Edit video by editing its transcript, built for researchers rather than video editors

From
$12/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; Reduct automatic transcription struggles with technical vocabulary, product names and strong accents, so teams working in specialist domains spend real time correcting transcripts or pay extra for the human transcription add-on, which erodes the cost advantage.
  • They diverge on capability: Greenphire covers ClinCard, Reduct covers Transcript-based editing.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and Reduct actually diverge.

Attributes where Greenphire and Reduct differ
AttributeGreenphireReduct
Starting priceOn request$12/month
Pricing modelquotePer user per month
PlatformsWeb, iOS, AndroidWeb, API

Identical on both: free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in Reduct

  • Transcript-based editing
  • Automatic transcription
  • Human transcription add-on
  • Highlight and tagging
  • Reel assembly
  • Redaction
  • Multicam sync
  • Collaborative commenting

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot Reduct
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot Reduct
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot Reduct
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot Reduct

Reduct

  • A research team that runs twenty customer interviews a quarter and needs stakeholders across product and design to watch and comment without buying them seatsnot Greenphire
  • A researcher assembling a five-minute highlight reel of user pain points for an executive review, working from transcript text rather than a video timelinenot Greenphire
  • A public defender office redacting faces and identifying details from body-camera and interview footage before disclosurenot Greenphire
  • A global insights team transcribing and translating interviews across several languages before coding them thematicallynot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

Reduct

  • Automatic transcription struggles with technical vocabulary, product names and strong accents, so teams working in specialist domains spend real time correcting transcripts or pay extra for the human transcription add-on, which erodes the cost advantage.
  • Transcription hours are a pooled annual allowance rather than monthly, so a team that front-loads a large research programme in one quarter can exhaust the year and face overage charges for the remaining nine months.
  • The Personal tier caps file size at 4GB, which is easily exceeded by an hour of multicam or high-bitrate recording, forcing an upgrade for reasons unrelated to the feature set.
  • Independent review coverage is very thin, so there is little public evidence to check vendor claims against, and buyers effectively have to rely on their own trial rather than peer signal.
  • The company has raised only about 4 million USD since 2018 and remains small, which makes enterprise vendor viability review and data-export planning genuinely necessary before you make it the home of years of research recordings.

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

Reduct

$12/month
  • Personal$12/month
    • 120 transcription hours per editor per year
    • Up to 10 commenters
    • 720p export
  • Professional$40/month
    • 300 transcription hours per editor per year
    • Up to 50 commenters
    • Timeline view
  • Enterprise$75/month
    • 4K export
    • SAML and Google SSO
    • SOC 2 Type II

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose Reduct if

  • You need transcript-based editing.
  • You work on Web, API.
  • You also want automatic transcription.
Reduct review

Questions people ask

Is Greenphire or Reduct better?
Neither clearly leads. Greenphire starts at On request and Reduct at $12/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or Reduct?
Greenphire starts at On request and Reduct at $12/month.
Does Greenphire or Reduct run on more platforms?
Greenphire runs on Web, iOS, Android. Reduct runs on Web, API.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what Reduct is typically brought in for.
What can Greenphire do that Reduct cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. Reduct covers Transcript-based editing, Automatic transcription, Human transcription add-on, Highlight and tagging.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

Reduct: How is Reduct priced?

Per editor per month: 12 USD on Personal, 40 on Professional and from 75 on Enterprise, with transcription supplied as a pooled annual hour allowance per editor.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

Reduct: Do stakeholders who only watch and comment need a paid seat?

No. Commenters are separate from editor seats and included up to 10 on Personal and 50 on Professional, which is the main reason research teams choose it.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

Reduct: Can I use it as a proper video editor?

Only up to a point. It handles transcript-driven cutting, reels and multicam sync, then exports to Premiere Pro or Final Cut Pro when you need real finishing.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

Reduct: Is there a free tier?

No. There is a 14-day trial on Professional with five hours of transcription, but no permanent free plan.

Share

Related pages

More on Greenphire

More on Reduct

Keep looking

Other head to heads